Delivery Order SPE2DB20D1109-SPE2DB25FP57C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor, AmerisourceBergen was selected...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens under contract 4569086102. This firm fixed price delivery order, issued on August 13, 2025, is part of a larger indefinite delivery contract (IDC) vehicle and represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a $9,646 delivery order to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Nemluvio 30 mg pens, with a completion date of September 10, 2025. This delivery order contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. The contract, awarded on July 18, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,929.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nemluvio 30 mg pens. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 19, 2025, and performance location in Conshohocken, Pennsylvania. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nemluvio 30 mg pens, a pharmaceutical product used in the treatment of certain medical conditions. This firm fixed-price delivery order is set to be completed by September 2, 2025, and will be fulfilled at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $1,929.20 delivery order (Contract No. 4568982332) to AmerisourceBergen Drug Corp for supply of Nemluvio 30 mg pens, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $7,716.80 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was awarded on August 12, 2025 without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under the company's...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP57CDelivery Order
The Defense Logistics Agency awarded a $3,858.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 4, 2025. This non-set-aside contract represents a competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery will be fulfilled at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, particularly supporting military and veteran healthcare systems. The contract falls within the company's broader portfolio of pharmaceutical deliveries for the Defense Logistics Agency, which encompasses specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. AmerisourceBergen's SPE2DX vehicle serves as a comprehensive global pharmaceutical support platform enabling flexible procurement of medical commodities to support military healthcare programs worldwide, with the potential for future multiple-award contracts under the DLA Troop Support's Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/13/25 |